Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia.

Saved in:

Bibliographic Details
Title:	Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia.
Authors:	Solberg, D. K., Bentsen, H., Refsum, H., Andreassen, O. A.
Source:	Acta Psychiatrica Scandinavica. Oct2015, Vol. 132 Issue 4, p293-300. 8p. 4 Charts.
Subjects:	Serum, Lipids, Fatty acids, Schizophrenia, Cell membranes
Abstract:	Objective Earlier reports indicate that patients with schizophrenia have altered lipid levels in serum and cell membranes. The purpose of this study was to determine the relationship between clinical characteristics and serum and membrane lipids. Method Fifty-five patients with schizophrenia and 51 healthy controls were included. The patients were characterized with Positive and Negative Syndrome Scale ( PANSS) and Global Assessment of Functioning ( GAF). Serum lipids [high- and low-density lipoprotein cholesterol ( HDL, LDL) and triglyceride ( TG)] and erythrocyte polyunsaturated fatty acids ( PUFA) were measured. Results Among the participants with schizophrenia, there was a significant correlation between serum triglyceride levels and PANSS-positive symptoms ( r = 0.28, P = 0.04), GAF-S ( r = −0.48, P = 0.001) and GAF-F ( r = −0.32, P = 0.01), and between HDL level and GAF-S ( r = 0.37, P = 0.008) and GAF-F ( r = 0.28, P = 0.04). Long-chain PUFA were significantly associated with PANSS-negative symptoms ( r = 0.52, P < 0.001), GAF-S ( r = −0.32, P = 0.02), and GAF-F ( r = −0.29, P = 0.04). The patients with schizophrenia had significantly higher TG ( P < 0.001) and lower HDL ( P < 0.001) levels than healthy controls. HDL was also lower in the subgroup ( n = 11) not receiving antipsychotic medication ( P = 0.02). Conclusion The results suggest associations between lipid profile and clinical characteristics. This may indicate a role for lipid biology in schizophrenia pathophysiology. [ABSTRACT FROM AUTHOR]
	Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Psychology and Behavioral Sciences Collection

Description
Abstract:	Objective Earlier reports indicate that patients with schizophrenia have altered lipid levels in serum and cell membranes. The purpose of this study was to determine the relationship between clinical characteristics and serum and membrane lipids. Method Fifty-five patients with schizophrenia and 51 healthy controls were included. The patients were characterized with Positive and Negative Syndrome Scale ( PANSS) and Global Assessment of Functioning ( GAF). Serum lipids [high- and low-density lipoprotein cholesterol ( HDL, LDL) and triglyceride ( TG)] and erythrocyte polyunsaturated fatty acids ( PUFA) were measured. Results Among the participants with schizophrenia, there was a significant correlation between serum triglyceride levels and PANSS-positive symptoms ( r = 0.28, P = 0.04), GAF-S ( r = −0.48, P = 0.001) and GAF-F ( r = −0.32, P = 0.01), and between HDL level and GAF-S ( r = 0.37, P = 0.008) and GAF-F ( r = 0.28, P = 0.04). Long-chain PUFA were significantly associated with PANSS-negative symptoms ( r = 0.52, P < 0.001), GAF-S ( r = −0.32, P = 0.02), and GAF-F ( r = −0.29, P = 0.04). The patients with schizophrenia had significantly higher TG ( P < 0.001) and lower HDL ( P < 0.001) levels than healthy controls. HDL was also lower in the subgroup ( n = 11) not receiving antipsychotic medication ( P = 0.02). Conclusion The results suggest associations between lipid profile and clinical characteristics. This may indicate a role for lipid biology in schizophrenia pathophysiology. [ABSTRACT FROM AUTHOR]
ISSN:	0001690X
DOI:	10.1111/acps.12388